
CAS 915038-27-6
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 Produkte.
Obeticholic Acid Impurity 2
CAS:Formel:C26H44O4Farbe und Form:White To Off-White SolidMolekulargewicht:420.63Obeticholic Acid-d7 (mixture of stereoisomers)
CAS:Kontrolliertes ProduktApplications 6-epi-Obeticholic Acid-d7 is an intermediate used in the synthesis of 6-Ethylchenodeoxycholic-d5 Acid (E899812), which is an isotope labelled compound of 6-Ethylchenodeoxycholic Acid (E899810), which is used in the investigative treatment of primary biliary cholangitis. Primary biliary cholangitis is an autoimmune disease of the liver that slowly progresses to cirrhosis.
References Ali, A. H, et al.: Expert Opin. Orphan Drugs, 4, 1011 (2016)Formel:C26D7H37O4Farbe und Form:WhiteMolekulargewicht:427.6686-epi-Obeticholic Acid
CAS:Kontrolliertes ProduktFormel:C26H44O4Farbe und Form:NeatMolekulargewicht:420.625(3a,5b,6b,7a)-6-Ethyl-3,7-dihydroxycholan-24-oic acid
CAS:Kontrolliertes Produkt(3a,5b,6b,7a)-6-Ethyl-3,7-dihydroxycholan-24-oic acid is a synthetic cholestane derivative that has been shown to be useful in the treatment of biliary cirrhosis. The synthesis of this compound involves the reduction of an ethyl ester using a grignard reagent followed by UV irradiation. The reaction yield is high with a large excess of Grignard reagent used. This compound has been shown to be active against hepatic bile ducts and liver cells in vitro. It also has anti-inflammatory effects and can be used as an alternative treatment for patients who are intolerant to ursodeoxycholic acid or chenodeoxycholic acid.Formel:C26H44O4Reinheit:Min. 95%Farbe und Form:SolidMolekulargewicht:420.63 g/mol



